nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxyphencyclimine—Hexylcaine—Diethylpropion—obesity	0.849	1	CrCrCtD
Oxyphencyclimine—CHRM3—muscle of abdomen—obesity	0.00165	0.591	CbGeAlD
Oxyphencyclimine—CHRM2—cardiovascular system—obesity	0.000221	0.0791	CbGeAlD
Oxyphencyclimine—CHRM1—cardiovascular system—obesity	0.000201	0.072	CbGeAlD
Oxyphencyclimine—CHRM3—adipose tissue—obesity	0.000159	0.0568	CbGeAlD
Oxyphencyclimine—CHRM2—endocrine gland—obesity	0.000152	0.0543	CbGeAlD
Oxyphencyclimine—CHRM3—digestive system—obesity	0.00015	0.0535	CbGeAlD
Oxyphencyclimine—CHRM1—endocrine gland—obesity	0.000138	0.0494	CbGeAlD
Oxyphencyclimine—CHRM3—endocrine gland—obesity	0.000124	0.0442	CbGeAlD
Oxyphencyclimine—CHRM3—Signaling Pathways—CNR1—obesity	1.97e-05	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GNB3—obesity	1.96e-05	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARGC1A—obesity	1.96e-05	0.000133	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—HMOX1—obesity	1.95e-05	0.000132	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CNR1—obesity	1.95e-05	0.000132	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TCF7L2—obesity	1.94e-05	0.000131	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TCF7L2—obesity	1.94e-05	0.000131	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AKT2—obesity	1.93e-05	0.000131	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—DRD2—obesity	1.93e-05	0.000131	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AKT2—obesity	1.93e-05	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—DRD2—obesity	1.92e-05	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3CG—obesity	1.92e-05	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TCF7L2—obesity	1.92e-05	0.00013	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3CG—obesity	1.91e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GNAS—obesity	1.91e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GCG—obesity	1.91e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PTPN1—obesity	1.91e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AKT2—obesity	1.91e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—DRD2—obesity	1.9e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GCG—obesity	1.9e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PTPN1—obesity	1.9e-05	0.000129	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3CG—obesity	1.89e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PTPN1—obesity	1.88e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GCG—obesity	1.88e-05	0.000128	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOB—obesity	1.87e-05	0.000127	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—PIK3CD—obesity	1.86e-05	0.000126	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PIK3CD—obesity	1.85e-05	0.000125	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PIK3CD—obesity	1.83e-05	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—POMC—obesity	1.83e-05	0.000124	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRL—obesity	1.82e-05	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—POMC—obesity	1.82e-05	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRL—obesity	1.82e-05	0.000123	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—POMC—obesity	1.8e-05	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRL—obesity	1.8e-05	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—STK11—obesity	1.8e-05	0.000122	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—STK11—obesity	1.79e-05	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CCL2—obesity	1.79e-05	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—LPL—obesity	1.79e-05	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CCL2—obesity	1.78e-05	0.000121	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PLG—obesity	1.77e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—RHOA—obesity	1.77e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—STK11—obesity	1.77e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PLG—obesity	1.77e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—RHOA—obesity	1.77e-05	0.00012	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CCL2—obesity	1.76e-05	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AKT2—obesity	1.76e-05	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—PIK3R1—obesity	1.75e-05	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PLG—obesity	1.75e-05	0.000119	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AKT2—obesity	1.75e-05	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—RHOA—obesity	1.75e-05	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PIK3R1—obesity	1.75e-05	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GPX1—obesity	1.74e-05	0.000118	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AKT2—obesity	1.73e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FOXO3—obesity	1.73e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PIK3R1—obesity	1.73e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADRB2—obesity	1.73e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FOXO3—obesity	1.73e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADRB2—obesity	1.72e-05	0.000117	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FOXO3—obesity	1.71e-05	0.000116	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADRB2—obesity	1.71e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SOCS1—obesity	1.7e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CD36—obesity	1.7e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SOCS1—obesity	1.7e-05	0.000115	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3CD—obesity	1.69e-05	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3CD—obesity	1.68e-05	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SOCS3—obesity	1.68e-05	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SOCS1—obesity	1.68e-05	0.000114	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SOCS3—obesity	1.68e-05	0.000113	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3CD—obesity	1.66e-05	0.000113	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SOCS3—obesity	1.66e-05	0.000112	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNB3—obesity	1.65e-05	0.000111	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNB3—obesity	1.64e-05	0.000111	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNB3—obesity	1.62e-05	0.00011	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—TYK2—obesity	1.62e-05	0.00011	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—PIK3CB—obesity	1.62e-05	0.00011	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—TYK2—obesity	1.62e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IGF2—obesity	1.62e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PIK3CB—obesity	1.61e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IGF2—obesity	1.61e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—RHOA—obesity	1.61e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—MTHFR—obesity	1.61e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—RHOA—obesity	1.6e-05	0.000109	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—GNAS—obesity	1.6e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—TYK2—obesity	1.6e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PIK3CB—obesity	1.6e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—GNAS—obesity	1.6e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IGF2—obesity	1.6e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3R1—obesity	1.59e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—RHOA—obesity	1.59e-05	0.000108	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3R1—obesity	1.59e-05	0.000107	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—GNAS—obesity	1.58e-05	0.000107	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARA—obesity	1.58e-05	0.000107	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.57e-05	0.000106	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOB—obesity	1.57e-05	0.000106	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOB—obesity	1.56e-05	0.000106	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOB—obesity	1.55e-05	0.000105	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL5—obesity	1.53e-05	0.000104	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AGT—obesity	1.53e-05	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL5—obesity	1.53e-05	0.000103	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL5—obesity	1.51e-05	0.000102	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—LPL—obesity	1.5e-05	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOE—obesity	1.5e-05	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—LPL—obesity	1.49e-05	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—FOXO1—obesity	1.49e-05	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RPS6KB1—obesity	1.48e-05	0.000101	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CAV1—obesity	1.48e-05	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—FOXO1—obesity	1.48e-05	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.48e-05	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—APOA1—obesity	1.48e-05	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—LPL—obesity	1.48e-05	0.0001	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3CB—obesity	1.47e-05	9.95e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—FOXO1—obesity	1.47e-05	9.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RPS6KB1—obesity	1.47e-05	9.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3CB—obesity	1.47e-05	9.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3CB—obesity	1.45e-05	9.82e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCD—obesity	1.38e-05	9.34e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCD—obesity	1.38e-05	9.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCD—obesity	1.36e-05	9.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3CG—obesity	1.35e-05	9.15e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—HTR2A—obesity	1.35e-05	9.14e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—C3—obesity	1.35e-05	9.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—HTR2A—obesity	1.35e-05	9.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—C3—obesity	1.34e-05	9.1e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—HTR2A—obesity	1.33e-05	9.03e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—C3—obesity	1.33e-05	9.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PPARG—obesity	1.3e-05	8.83e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—POMC—obesity	1.29e-05	8.71e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IRS2—obesity	1.28e-05	8.69e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGT—obesity	1.28e-05	8.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IRS2—obesity	1.28e-05	8.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—INS—obesity	1.28e-05	8.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGT—obesity	1.28e-05	8.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IRS2—obesity	1.27e-05	8.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGT—obesity	1.27e-05	8.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOE—obesity	1.26e-05	8.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—LEP—obesity	1.26e-05	8.5e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—LEP—obesity	1.25e-05	8.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOE—obesity	1.25e-05	8.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CAV1—obesity	1.24e-05	8.42e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—APOA1—obesity	1.24e-05	8.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CAV1—obesity	1.24e-05	8.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOE—obesity	1.24e-05	8.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—LEP—obesity	1.24e-05	8.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—APOA1—obesity	1.24e-05	8.38e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CAV1—obesity	1.23e-05	8.31e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—APOA1—obesity	1.23e-05	8.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ESR1—obesity	1.2e-05	8.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ESR1—obesity	1.2e-05	8.09e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3CD—obesity	1.19e-05	8.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—F2—obesity	1.18e-05	8.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PRKCB—obesity	1.18e-05	8.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ESR1—obesity	1.18e-05	8.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—F2—obesity	1.18e-05	7.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PRKCB—obesity	1.18e-05	7.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ALB—obesity	1.17e-05	7.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—BAD—obesity	1.17e-05	7.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—F2—obesity	1.17e-05	7.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PRKCB—obesity	1.17e-05	7.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—BAD—obesity	1.17e-05	7.9e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—BAD—obesity	1.16e-05	7.82e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3CG—obesity	1.13e-05	7.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3CG—obesity	1.13e-05	7.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3R1—obesity	1.12e-05	7.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—NOS3—obesity	1.12e-05	7.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IRS1—obesity	1.12e-05	7.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3CG—obesity	1.12e-05	7.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IRS1—obesity	1.12e-05	7.56e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IRS1—obesity	1.11e-05	7.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—POMC—obesity	1.08e-05	7.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—POMC—obesity	1.08e-05	7.28e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—INS—obesity	1.07e-05	7.26e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—INS—obesity	1.07e-05	7.24e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—POMC—obesity	1.06e-05	7.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—INS—obesity	1.06e-05	7.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CCL2—obesity	1.06e-05	7.15e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CCL2—obesity	1.05e-05	7.12e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CCL2—obesity	1.04e-05	7.05e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IGF1—obesity	1.04e-05	7.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT2—obesity	1.04e-05	7.02e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3CB—obesity	1.04e-05	7.01e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IGF1—obesity	1.03e-05	7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT2—obesity	1.03e-05	7e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PTGS2—obesity	1.03e-05	6.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IGF1—obesity	1.02e-05	6.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT2—obesity	1.02e-05	6.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3CD—obesity	9.96e-06	6.74e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3CD—obesity	9.93e-06	6.72e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	9.87e-06	6.68e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—SERPINE1—obesity	9.85e-06	6.67e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	9.84e-06	6.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3CD—obesity	9.83e-06	6.66e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—SERPINE1—obesity	9.82e-06	6.65e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	9.74e-06	6.59e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—SERPINE1—obesity	9.73e-06	6.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TYK2—obesity	9.58e-06	6.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TYK2—obesity	9.55e-06	6.47e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RHOA—obesity	9.51e-06	6.43e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RHOA—obesity	9.48e-06	6.41e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TYK2—obesity	9.46e-06	6.4e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—NOS3—obesity	9.41e-06	6.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3R1—obesity	9.41e-06	6.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RHOA—obesity	9.38e-06	6.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—NOS3—obesity	9.38e-06	6.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3R1—obesity	9.38e-06	6.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3R1—obesity	9.29e-06	6.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—NOS3—obesity	9.29e-06	6.29e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—PIK3CA—obesity	8.96e-06	6.07e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—PIK3CA—obesity	8.93e-06	6.05e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—PIK3CA—obesity	8.85e-06	5.99e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MTOR—obesity	8.68e-06	5.88e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3CB—obesity	8.68e-06	5.88e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MTOR—obesity	8.66e-06	5.86e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3CB—obesity	8.66e-06	5.86e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MTOR—obesity	8.57e-06	5.8e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3CB—obesity	8.57e-06	5.8e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AKT1—obesity	8.06e-06	5.46e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AKT1—obesity	8.04e-06	5.44e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AKT1—obesity	7.96e-06	5.39e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—IL6—obesity	7.94e-06	5.37e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—IL6—obesity	7.91e-06	5.35e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—IL6—obesity	7.83e-06	5.3e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MMP9—obesity	7.55e-06	5.11e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MMP9—obesity	7.52e-06	5.09e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MMP9—obesity	7.45e-06	5.04e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MAPK8—obesity	7.34e-06	4.97e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AKT1—obesity	7.32e-06	4.96e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MAPK8—obesity	7.32e-06	4.95e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AKT1—obesity	7.3e-06	4.94e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MAPK8—obesity	7.25e-06	4.91e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AKT1—obesity	7.23e-06	4.89e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—STAT3—obesity	6.71e-06	4.54e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—STAT3—obesity	6.69e-06	4.53e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—STAT3—obesity	6.62e-06	4.48e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—PIK3CA—obesity	6.31e-06	4.27e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—MYC—obesity	6.24e-06	4.22e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—TGFB1—obesity	6.22e-06	4.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—MYC—obesity	6.22e-06	4.21e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—TGFB1—obesity	6.2e-06	4.2e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—MYC—obesity	6.16e-06	4.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—TGFB1—obesity	6.14e-06	4.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PIK3CA—obesity	5.29e-06	3.58e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PIK3CA—obesity	5.28e-06	3.57e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PIK3CA—obesity	5.23e-06	3.54e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AKT1—obesity	5.16e-06	3.49e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—IL6—obesity	4.69e-06	3.17e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—IL6—obesity	4.67e-06	3.16e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—IL6—obesity	4.63e-06	3.13e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AKT1—obesity	4.32e-06	2.93e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AKT1—obesity	4.31e-06	2.92e-05	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AKT1—obesity	4.27e-06	2.89e-05	CbGpPWpGaD
